What is explexploramed?

ExploraMed is a medical device incubator focused on patient-driven solutions to persistent medical problems. We are dedicated to significantly improving patients' quality of life through cutting edge, cost effective device solutions.

What is neneotract and Willow?

NeoTract has developed a less invasive device for treating benign prostatic hyperplasia (BPH) – the non-cancerous enlargement of the prostate gland in men as they age, which constricts the urethra and causes difficult urination. Willow is a mission-driven startup that reimagines the traditional breast pump.

What companies have been acquired by exploramed?

Notable transactions from the ExploraMed portfolio include NeoTract , acquired by Teleflex in 2017, Nuelle, acquired by Aytu in 2017, Acclarent, acquired by J&J in 2010, EndoMatrix, acquired by C.R. Bard in 1997 and TransVascular, acquired by Medtronic in 2003. On-going ExploraMed ventures include Moximed, Willow and ExploraMed V.

Who is EB bright at exploramed?

At the ExploraMed incubator, Eb Bright has many years of technology development, company formation and financing experience. He is a founder of several companies, a patent attorney and has served on the executive management teams of many start-up companies in multiple capacities (Acclarent, NeoTract , Vibrynt, Moximed, Nuelle, Willow).

Neotract Sheet Info - Finder Manual

Listing Results Neotract Sheet Info

About 20 results and 4 answers.

Neotract — ExploraMed

NeoTract® is company focused on the unmet needs in Urology and has pioneered the development of UroLift™, a minimally invasive treatment designed to treat lower urinary tract symptoms due benign prostatic hypertrophy (BPH).

Neotract, Inc. Company Profile Pleasanton, CA

Company Description: NeoTract, Inc. is located in Pleasanton, CA, United States and is part of the Medical Equipment and Supplies Manufacturing Industry. NeoTract, Inc. has 12 total employees across all of its locations and generates $5.52 million in sales (USD). (Sales figure is modelled).
Employees: 12
Phone: (925) 401-0700
Location: 4155 Hopyard Rd, Pleasanton, 94588-8534, CA

NeoTract Company Profile - Office Locations, Competitors

NeoTract is a company dedicated to developing minimally invasive devices in the field of urology. It offers UroLift, a system that helps to treat men suffering from benign prostatic hyperplasia. Employee Rating 4.4 More NeoTract was founded in 2004 and is headquartered in Pleasanton, CA, US Report incorrect company information
HQ: Pleasanton, CA, US
Founded: 2004
Location: 4155 Hopyard Rd, Pleasanton, US

NeoTract

Revenues of approximately $51 million in 2016 compared to approximately $18 million in 2015, representing 178% year-over-year growth. During 2017, NeoTract’s revenues are expected to be between $115 million to $120 million. Anticipate revenues to grow at least 40% in 2018. Purchased by Teleflex in September, 2017. NeoTract Company Background
Author: Ray Clubb
Last modified by: Greenwood, Ray
Created Date: 12/08/2015 12:50:42
Title: PowerPoint Presentation

Neotract EquityNet

NeoTract This is a community-generated profile. If you would like to claim this profile, contact us. Company Overview NeoTract, Inc. develops surgical devices for urological and gynecological disorders. The company was incorporated in 2004 and is based in Mountain View, California. Read More Unlock Company Profile
Company Age: 17 years, 11 months
Sub-Industry: Other Healthcare
Employees: 15

Teleflex Incorporated to Acquire NeoTract

Sep 05, 2017 . Founded in 2004, NeoTract is a privately-held medical device company that has developed and commercialized the FDA-cleared UroLift® System, a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia, or BPH.

NeoTract Company Profile: Acquisition & Investors

The company's initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function. Contact Information Website www.NeoTract.com Ownership Status Acquired/Merged (Operating Subsidiary) Financing Status

ReviewSet - neotract.pilgrimasp.com

Example Issue Review Escalation Business Scenario. The following Reviewers are included in the Routing sheet for Final Issue Review: · Level 1 QA Coordinator · Level 2 QA Coordinator · Level 2 QA Manager Step 1 – No escalation will be used for Level two; however, the Level one QA Coordinators will have three business days to approve the issue from the date the issue has …

Neotract - Crunchbase Company Profile & Funding

Legal Name NeoTract, Inc. Company Type For Profit Phone Number 925-401-0700 NeoTract, Inc. develops surgical devices for urological and gynecological disorders. Lists Featuring This Company Cornell University Alumni Founded Companies 1,930 Number of Organizations • $76.8B Total Funding Amount • 6,197 Number of Investors

NeoTract Inc - Company Profile and News - Bloomberg

NeoTract Inc NeoTract, Inc. develops and manufactures medical devices for urologists. The Company offers minimally invasive devices to treat lower …

MAUDE Adverse Event Report: NEOTRACT, INC. UROLIFT

NeoTract, INC. UROLIFT IMPLANTABLE TRANSPROSTATIC TISSUE RETRACTOR SYSTEM: Back to Search Results: Device Problem Adverse Event Without Identified Device or Use Problem (2993) Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)

For Patients - UroLift

Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men age. BPH is very common, affecting nearly 40 million Americans and 500 million men worldwide. More than 40% of men in their 50s and more than 70% of men in their 60s have BPH. 1 While BPH is a benign condition and unrelated to prostate cancer, it can ...

MAUDE Adverse Event Report: NEOTRACT, INC. UROLIFT

MDR Report Key: 12665049: MDR Text Key: 277771104: Report Number: MW5104768: Device Sequence Number: 1: Product Code: PEW Reporter Country Code: US: Number of Events ...

SEC FORM D/A

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996 ...

TELEFLEX INCORPORATED Files An 8-K Other Events

Nov 16, 2017 . Attached hereto as Exhibit 99.1 and incorporated herein by reference are the audited NeoTract, Inc. consolidated balance sheet as of December 31, 2016, consolidated statements of operations and ...

Neotract, Inc. in Pleasanton, NM Company Info & Reviews

NeoTract, Inc. is a New Mexico Foreign Profit Corporation filed On October 16, 2017. The company's filing status is listed as Active and its File Number is 5538718.
Location: CA

Frequently Asked Questions

What is explexploramed?

ExploraMed is a medical device incubator focused on patient-driven solutions to persistent medical problems. We are dedicated to significantly improving patients' quality of life through cutting edge, cost effective device solutions.
What is neneotract and Willow?

NeoTract has developed a less invasive device for treating benign prostatic hyperplasia (BPH) – the non-cancerous enlargement of the prostate gland in men as they age, which constricts the urethra and causes difficult urination. Willow is a mission-driven startup that reimagines the traditional breast pump.
What companies have been acquired by exploramed?

Notable transactions from the ExploraMed portfolio include NeoTract, acquired by Teleflex in 2017, Nuelle, acquired by Aytu in 2017, Acclarent, acquired by J&J in 2010, EndoMatrix, acquired by C.R. Bard in 1997 and TransVascular, acquired by Medtronic in 2003. On-going ExploraMed ventures include Moximed, Willow and ExploraMed V.
Who is EB bright at exploramed?

At the ExploraMed incubator, Eb Bright has many years of technology development, company formation and financing experience. He is a founder of several companies, a patent attorney and has served on the executive management teams of many start-up companies in multiple capacities (Acclarent, NeoTract, Vibrynt, Moximed, Nuelle, Willow).